Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 5, 2004, Pages 924-929

  Mogilyansky, Elena ^a   Loa, Chien Chang ^a   Adelson, Martin E ^a   Mordechai, Eli ^a   Tilton, Richard C ^a  

^a Medical Diagnostic Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; C6 ANTIBODY; C6 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ACCURACY; ANTIBODY DETECTION; ARTICLE; BORRELIA BURGDORFERI; C6 LYME ANTIBODY TEST; DIAGNOSTIC KIT; DRUG INDUSTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LYME DISEASE; PERFORMANCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; STANDARD; WESTERN BLOTTING;

ANTIBODIES, BACTERIAL; BLOTTING, WESTERN; BORRELIA BURGDORFERI; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYME DISEASE; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 4644312372     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.5.924-929.2004     Document Type: Article

References (11)

1. Bakken, L. L., K. L. Case, S. M. Callister, N. J. Bourdeau, and R. F. Schell. 1992. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA 268:891-895.
2. Centers for Disease Control and Prevention. 1995. Recommendation for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Morb. Mortal. Wkly. Rep. 44:590-591.
3. Fawcett, P. T., C. D. Rose, S. M. Budd, and K. M. Gibney. 2001. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis. Clin. Diagn. Lab. Immunol. 8:79-84.
4. Fister, R. D., L. A. Weymouth, J. C. McLaughlin, R. W. Ryan, and R. C. Tilton. 1989. Comparative evaluation of three products for the detection of Borrelia burgdorferi antibody in human serum. J. Clin. Microbiol. 27:2834-2837.
5. Hofmann, H. 1996. Lyme borreliosis-problems of serological diagnosis. Infection 24:470-472.
6. Lawrenz, M. B., J. M. Hardham, R. T. Owens, J. Nowakowski, A. C. Steere, G. P. Wormser, and S. J. Norris. 1999. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J. Clin. Microbiol. 37:3997-4004.
7. Liang, F. T., E. Aberer, M. Cinco, L. Gern, C. M. Hu, Y. N. Lobet, M. Ruscio, P. E. Voet, Jr., V. E. Weynants, and M. T. Philipp. 2000. Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL. J. Infect. Dis. 182:1455-1462.
8. Liang, F. T., A. C. Steere, A. R. Marques, B. J. B. Johnson, J. N. Miller, and M. T. Philipp. 1999. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J. Clin. Microbiol. 37:3990-3996.
9. Magnarelli, L. A., M. Lawrenz, S. J. Norris, and E. Fikrig. 2002. Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis. J. Med. Microbiol. 51:649-655.
10. Tilton, R. C. 2003. New tests for Lyme disease. Clin. Microbiol. Newsl. 25:145-149.
11. Tilton, R. C., M. N. Sand, and M. Manak. 1997. The Western immunoblot for Lyme disease: determination of sensitivity, specificity, and interpretive criteria with use of commercially available performance panels. Clin. Infect. Dis. 25(Suppl. 1):S31-S34.